A way forward has been found to resolve the differences between the EU's controversial guideline on good manufacturing practices for advanced therapies and the international guideline of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) on the same topic.
A PIC/S working group that was convened last year to look into this matter, along with representatives of the World Health Organization, has suggested that the divergences between the two...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?